Concentric Analgesics: Funding, Investors & Team (Oct 2026)
Concentric Analgesics is a biotechnology company focused on developing non-opioid therapeutics for the management of acute and chronic pain. The company is driven by a mission is to dramatically improve the lives of patients by developing breakthrough non-opioid pain therapeutics that address significant medical needs. Concentric Analgesics was founded in 2014 and is headquartered in San Francisco, California.
Concentric Analgesics has raised $20.0M across 1 funding round on record, the most recent a Convertible Note of $20.0M announced in Jan 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Concentric Analgesics Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Concentric Analgesics Funding Rounds
Concentric Analgesics Founders and Leadership Team
Contact details for the Concentric Analgesics team: 1 of 1 has an email address on file.
Start 14-day free trial →Concentric Analgesics Funding Compared to Other Biotechnology Startups
Concentric Analgesics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Concentric Analgesics in Biotechnology and San Francisco
Companies Similar to Concentric Analgesics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Concentric Analgesics Funding FAQs
What does Concentric Analgesics do?
Concentric Analgesics is a biotechnology company focused on developing non-opioid therapeutics for the management of acute and chronic pain. The company is driven by a mission is to dramatically improve the lives of patients by developing breakthrough non-opioid pain therapeutics that address significant medical needs. Concentric Analgesics was founded in 2014 and is headquartered in San Francisco, California.
How much funding has Concentric Analgesics raised?
Concentric Analgesics has raised $20.0M across 1 round on record. The most recent is a Convertible Note of $20.0M announced in Jan 2022.
When did Concentric Analgesics last raise funding?
Concentric Analgesics' most recent funding round on record is a Convertible Note of $20.0M, announced in Jan 2022.
Who is the CEO of Concentric Analgesics?
Frank Bellizzi is listed as CEO at Concentric Analgesics.
Where is Concentric Analgesics headquartered?
Concentric Analgesics is based in San Francisco, California, United States.
How many employees does Concentric Analgesics have?
Concentric Analgesics is in the 11-50 employee band.
How does Concentric Analgesics' funding compare to other Biotechnology startups?
Concentric Analgesics' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Concentric Analgesics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Concentric Analgesics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.